velmanase alpha

Ukraine

Drugs containing this active substance

  • LAMZEDE

    The drug is intended for enzyme replacement therapy in patients with mild to moderate alpha-mannosidosis (provided that neurological manifestations of the disease are not yet pronounced).

    Form: powder for solution for infusion

    Active substance Dosage
    velmanase alpha 10 mg

    ATC: A16AB15

    Manufacturer: Pateon Italia S.p.A. (manufacturing of medicinal product, testing at release, stability testing, primary packaging)